Clinical role of post-angioplasty hyperemic microvascular resistances in chronic ischemic left ventricular

Riccardo Gorla1, Edoardo Verna, Simone Scotti

  • 1aDepartment of Cardiology bDepartment of Nuclear Medicine, Ospedale di Circolo and Fondazione Macchi, University of Insubria, Varese, Italy.

Insights

Increased hyperemic microvascular resistances (HMRs) after percutaneous coronary intervention (PCI) indicate poor functional recovery in patients with chronic ischemic left ventricular dysfunction (CILVD). This finding aids in predicting outcomes post-PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Physiology

Background:

  • Chronic ischemic left ventricular dysfunction (CILVD) significantly impacts cardiac function.
  • Percutaneous coronary intervention (PCI) aims to restore myocardial perfusion.
  • Assessing microvascular function post-PCI is crucial for predicting recovery.

Purpose of the Study:

  • To evaluate the relationship between hyperemic microvascular resistances (HMRs) and myocardial functional recovery after PCI in CILVD patients.
  • To determine if post-PCI HMRs can predict the improvement in left ventricular ejection fraction (LVEF) and contractility.

Main Methods:

  • Retrospective study of 48 CILVD patients undergoing PCI.
  • HMRs assessed pre- and post-PCI using a dual-sensor intracoronary pressure-flow wire.
  • Myocardial perfusion (summed rest score, SRS-T) and contractility (wall motion index, WMSI-T, LVEF) evaluated by SPECT and echocardiography.

Main Results:

  • Patients were grouped by post-PCI HMRs (>2 vs. <2 mmHg/cm/s).
  • Significant improvements in LVEF, WMSI-T, and SRS-T were observed only in the group with lower post-PCI HMRs.
  • Post-PCI HMRs >1.95 mmHg/cm/s predicted the absence of LVEF and WMSI-T improvement with high accuracy.

Conclusions:

  • Elevated post-PCI HMRs are associated with a lack of functional improvement in the revascularized myocardium of CILVD patients.
  • HMRs serve as a valuable predictor for functional recovery after PCI in this population.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
813
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
529